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Summary
Primary malignant lyphoma of the genital tract is a rare disease. It’s frequency has been reported to be less than 1% 
among extranodal lymphoma in women. The main symptoms are abnormal vaginal bleeding, unclear abdominal/pelvic 
pain, dyspareunia and/or urinary obstruction.
We present a 77-year old woman with a primary malignant lymphoma of the uterine corpus. Non-Hodgkin diﬀ use 
large B cell lymphoma was diagnosed in a curett age specimen. Positron emission  tomography/ computed tomography 
(PET-CT) fi ndings showed a lesion confi ned to the uterus without evidence of disease in the head, neck, chest or abdomen. 
There were no enlarged lymph nodes. The patient was treated by chemotherapy.
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PRIMARNI MALIGNI LIMFOM TIJELA MATERNICE: 
PRIKAZ SLUČAJA
Sažetak
Primarni maligni limfom genitalnog trakta je rijetka bolest. Učestalost je manja od 1% među limfomima izvan limfnih 
čvorova. Glavni simptomi su abnormalno vaginalno krvarenje, nejasna abdominalna/zdjelična bol, dispareunija i/ili uri-
narna opstrukcija.
Mi predstavljamo slučaj 77-godišnje pacijentice sa primarnim malignim limfomom tijela maternice. Non-Hodgkin 
difuzni velikostanični B limfom je dijagnosticiran u uzorku frakcionirane kiretaže. Imunohistokemijsko bojanje je potvrdilo 
dijagnozu. PET/CT je potvrdio bolest unutar maternice bez znakova bolesti u glavi, vratu, prsima ili trbuhu. Nije bilo uve-
ćanih limfnih čvorova. Pacijentica je liječena kemoterapijom.




Lymphomas are the most common haemato-
logical cancers and they are divided into two 
groups, non-Hodgkin (70-80%) and Hodgkin (20-
30%) lymphomas (1).
Primary malignant lyphoma (PML) of the 
genital tract is a rare disease representing extra-
nodal lymphomas with less than 1% (2,3).
The most common site where Non-Hodg-
kin’s lymphomas (NHL) occur in genital tract is 
the ovary. Infrequently, NHL may also involve 
the uterus (4).
The most common diagnosis is diﬀ use large 
B-cell lymphoma. The main symptoms are abnor-
mal vaginal bleeding, unclear abdominal/pelvic 
pain, dyspareunia and/or urinary obstruction 
(1,5). Most patients lack classical symptoms asso-
ciated with B-cell lymphomas such as fever, fa-
tigue, night sweats and weight loss (3). NHLs in-
volving the uterus may be either low-stage neo-
plasms that probably arise in the uterus (primary) 
or systemic neoplasms with secondary involve-
ment (4).
CASE REPORT
We present a 77-year old woman with a PML 
of the uterine corpus. She has been menopausal 
for 22 years. In her medical history, she had no 
Figure 3. Immunohistochemical analysis revealed strongly posi-
tive staining with leukocyte common antigen (LCA) (magnifi ca-
tion 40x).
Figure 1. Histologic specimen showing diﬀ use large B cell lym-
phoma and endometrial tissue (hemalaun eosin staining, magni-
fi cation 10x).
Figure 2. Histologic specimen showing diﬀ use large B cell lym-
phoma (hemalaun eosin staining, magnifi cation 40x).
serious illnesses except undergoing surgery for 
ovarian cyst 40 years ago. She did not have any 
symptoms. During the control check up, she un-
derwent pelvic ultrasound (US) that revealed a 3.2 
x 3.4 cm inhomogeneous lesion located within the 
uterine cavity (resistance index /RI/ 0.38). Non-
Hodgkin diﬀ use large B cell lymphoma was diag-
nosed in a curett age specimen (Figure 1-3.). Ultra-
sound also revealed a cystic lesion in the right 
ovary. Microscopically, each cell showed a large 
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or medium size bullous nucleus, the distinct nu-
cleolus, frequent cell division, and a small amount 
of cytoplasm. Immunohistochemical staining con-
fi rmed the diagnosis. Positron emission tomogra-
phy/computed tomography (PET/CT) fi ndings 
showed a lesion confi ned to the uterus without 
evidence of disease in the head, neck, chest or ab-
domen. There were no enlarged lymph nodes. The 
patient was treated by chemotherapy. Treatment 
was started with series of rituximab, cyclophos-
phamide, doxorubicin, vincristine and prednisone 
(R-CHOP) chemotherapy under supervision of 
the hematology department. After 8 courses of 
chemotherapy, a control CT was performed which 
showed complete remission. Our patient had a re-
lapse and multiple recurrences of lymphoma with 
progression and death three years after the initial 
diagnosis.
DISCUSSION
Malignant lymphomas of the uterus can oc-
cure in patients of diﬀ erent ages, the median is the 
fourth decade (6). The incidence of extranodal 
lymphomas including MLs of the genital tract has 
increased in the past decades both in the United 
States and western Europe (7). Lymphomas pre-
senting with initial manifestations of female geni-
tal tract disease are extremely rare (3). Patients 
usually present with vaginal bleeding and ab-
dominal or pelvic discomfort, but also the tumors 
are discovered as a result of a routine check-up 
(2,3), as presented in our case. Because patients 
have often nonspecifi c symptoms, it usually takes 
longer before the correct diagnosis is made. The 
most common symptom of the primary uterine 
lymphomas is vaginal bleading (2,5). Immunohys-
tochemical examination is necessary to determine 
the type and subtype of lymphoma (2). Diﬀ use 
large B-cell lymphoma is the most frequent histo-
logical subtype and is responsible for 25% cases of 
NHL (7).
Computed tomography is the preferred im-
aging method because it can give information 
about the lesion size and extent of the disease. 
With the information given by CT we can plan 
treatment regimen and follow response to treat-
ment (2). However, MRI has a greater ability to 
diﬀ erentiate uterine and cervical lymphomas 
from other entities (5). Uterine lymphoma can 
mimic cervical or endometrial carcinoma or myo-
ma. They are presented on imaging studies from 
diﬀ use enlargements of the uterus to localized 
masses who are most commonly not sharply de-
lineated (6).
Due to low incidence of primary uterine ma-
lignant lymphoma, large patient series describing 
the optimal treatment method are not available; 
therefore, the treatment of patients with a primary 
uterine lymphoma needs to be individualized 
(1,5). MLs aﬀ ecting the female genital tract can be 
under diagnosed because they are unexpected in 
these sites and can be misdiagnosed as some other 
types of tumors (7). Patients with extranodal forms 
of malignant lymphomas are usually presented to 
and treated by specialists who deal with that par-
ticular body system (1). The prognosis for extra-
nodal lymphomas, in general, is worse than for 
nodal primarily due to delayed or inaccurate di-
agnosis and inadequate treatment (7). R-CHOP 
protocol, the same we used with our patient, 
proved to improve 5-year survival rates signifi -
cantly in patients over 60 years old and with the 
diagnosis of diﬀ use large B-cell lymphoma (5). 
This protocol has also been used in initial and re-
currence treatment of aggressive NHLs and has 
improved overall survival for this disease (1).
CONCLUSION
Primary uterine lymphoma of the genital tract 
is extremely rare. Although the gynaecologists 
will rarely deal with extranodal lymphomas they 
should include them in diﬀ erential diagnosis of 
uterine pathology. Histology is essential to reach a 
correct diagnosis and appropriate treatment for 
this malignancy.
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